相关实验视频

Updated: May 10, 2026

Orthotopic Liver Transplantation in Rats

Orthotopic Liver Transplantation in Rats

Published on: July 1, 2012

[用于横内肝脏移植系统的移植]

I I Zatevakhin¹, V N Shipovskiy^1,2, M Sh Tsitsiashvili¹

¹Russian National Research Medical University named after N.I. Pirogov of the of the Ministry of Health of the Russian Federation, 117997, Moscow, Russian Federation.

Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery

|March 9, 2026

概括

E-Luminexx + LifeStream 支架结构在跨内肝移植系统 (TIPS) 程序中显示出与 Hanarostent 植入物相比的12个月初级通透性,这表明两者都有良好的临床结果.

科学领域:

干预性放射学干预性放射学
血管外科血管外科
肝病学肝病学是一种肝病学.

背景情况:

横性肝脏内移植系统性分流 (TIPS) 是管理门门高血压的关键程序.
支架移植的透度是成功的TIPS结果的一个关键决定因素.
对比不同的支架移植设备对于优化临床实践至关重要.

研究的目的:

在TIPS程序中使用的两种不同的支架移植设备的临床结果进行比较.
为了评估E-Luminexx + LifeStream支架结构与Hanarostent移植的初级通透率.
评估这些设备在TIPS创建中的短期和长期有效性.

主要方法:

89名接受TIPS治疗的患者的回顾性分析.
根据使用的支架移植,患者被分为两组:E-Luminexx + LifeStream (I组,n=50) 和Hanarostent (II组,n=39).
卡普兰-梅尔分析被用来评估各种时间点的累积初级通透性.

主要成果:

在12个月后的累积初级通透率在两组之间是可比的 (85.3%的E-Luminexx + LifeStream与Hanarostent的76.6%相比).
长期穿透性有利于E-Luminexx + LifeStream支架结构,在24个月和48个月显示出更高的比率.
这两种设备在TIPS后表现出良好的初始穿透率.

结论:

结合的E-Luminexx + LifeStream支架结构为TIPS提供了与Hanarostent移植相比较的短期通透性.
E-Luminexx + LifeStream可能会提供优越的长期通透性,这表明持续的TIPS功能的潜在优势.
这两种支架移植选项对于TIPS程序都是可行的,设备选择可能会受到期望的长期穿透性结果的影响.

关键词:

E-Luminexx + 生命流 (LifeStream) 是一个电子光源.汉纳罗斯坦特的情况.提示提示 (TIPS) 是一个提醒.门高血压门高血压

更多相关视频

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

相关概念视频

Portal Hypertension

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...